https://finance.yahoo.com/news/provention-bios-2-9b-acquisition-170448768.html
Sanofi SA (NASDAQ: SNY) has agreed to acquire Provention Bio Inc (NASDAQ: PRVB) for $25.00 per share in cash, representing an equity value of approximately $...
Create an account or login to join the discussion